Introduction
Preparations from the herb and/or flowers of Filipendula ulmaria (L.) Maxim (Rosaceae) (meadowsweet) have been used traditionally since the late 16th
and 17th century for the treatment of inflammatory diseases and as a diuretic and
antirheumatic. F. ulmaria is administered as herbal tea, as a powdered herbal substance in solid dosage form
for oral use, and as a tincture. In some countries of the European Union, tinctures
or possible tincture-based products containing alcoholic extracts of Filipendulae
Herba are on the market as food supplements used for complaints such as rheumatic
and arthritic pain [1 ]. Because of its anti-inflammatory properties, Harbourne et al. studied the phenolic
content of aqueous F. ulmaria extracts for their incorporation into a beverage as a functional ingredient [2 ].
It has been shown that meadowsweet contains phenolic constituents such as flavonoid
aglycons (e.g., quercetin, kaempferol), glycosylated flavonoids (e.g., rutin, hyperoside,
quercitrin, avicularin, astragalin), and hydrolysable tannins (tellimagrandin I and
II, rugosin A, B, D, and E) as well as salicylates (salicylic acid, methyl salicylate,
salicylaldehyde, salicylalcohol and their glycosides) [3 ], [4 ], [5 ], [6 ], [7 ], [8 ], [9 ]. Only a limited number of non-phenolic constituents such as phytosterols, carotenoids,
triterpenes, and chlorophyll derivatives have been reported [7 ], [10 ], [11 ]. In view of the phenolic nature of the main constituents reported in meadowsweet,
extensive metabolisation after oral intake before absorption can be expected [12 ]. Indeed, natural products are often pro-drugs, e.g., glycosides, which must undergo
in vivo metabolic conversion (activation). Salicylic acid, the in vivo metabolite of salicylic alcohol derivatives present in the plant extract, is responsible
for part of the pharmacological activity [5 ], [13 ]. Nevertheless, the chemistry of meadowsweet has not been studied in a comprehensive
manner and its active constituents remain to be revealed.
Phytochemical studies have often dedicated their efforts towards the identification
of a limited number of metabolites, which renders the available information fragmented.
Usually detectors designed for targeted analysis such as photodiode array detectors
(PDA) and triple quadrupole mass spectrometry detectors are used [2 ], [3 ], [4 ], [5 ], [7 ], [8 ], [9 ], [14 ]. These detectors often do not provide sufficient structural information for compound
identification in complex mixtures without the use of analytical standards [15 ]. Due to the lack of commercially available analytical standards, identification
of unknown metabolites, therefore, often result in tedious multistep purification
protocols involving solvent extractions followed by sequential fractionations with
open-bed liquid chromatography (LC) and/or (semi) preparative high-performance LC
(HPLC) [6 ], [16 ]. To obtain unambiguous structure elucidation and compound identification, nuclear
magnetic resonance (NMR) still remains indispensable. NMR is, however, not a very
sensitive technique and requires compound purification before detection to allow proper
structure elucidation. One of the possible strategies to circumvent this sensitivity
issue is the use of a solid-phase extraction (SPE) interface in an LC‐SPE‐NMR configuration
[17 ].
In the past decade, the usage of analytical instrumentation has shifted from simple
analytical instrumentation, such as HPLC-PDA, towards more selective and more complex
separation and detection systems, such as ultrahigh-performance liquid chromatography-photodiode
array-accurate mass mass spectrometry (UHPLC-PDA-amMS), to achieve more definite compound
identification [18 ]. Accurate mass MS detectors facilitate the tentative identification of unknown metabolites
without the use of analytical standards. Orbitrap MS detectors can routinely generate
mass spectra with a resolving power up to 140 000 at full width at half maximum (FWHM)
and obtain mass accuracies within 1–2 ppm; this enables the calculation of the most
probable molecular formulae of the generated precursor and product ions [19 ]. This utility combined with the selectivity and sensitivity of current hyphenated
UHPLC-PDA-amMS systems has paved the way towards generic phytochemical analysis and
has led to a very significant impact of MS-based technologies in the field of metabolomics
[18 ]. However, a wide diversity of phytochemical structures is produced in nature. Consequently,
the complete metabolite profile cannot be extracted with one solvent nor be analysed
with one analytical method. Comprehensive phytochemical characterisation should, therefore,
be performed with several analytical methods to (ideally) cover the whole range of
plant metabolites present in plants.
The goal of the current study was to explore the phytochemical composition of Filipendulae
Ulmariae Herba in a comprehensive manner. A generic characterisation platform consisting
of two UHPLC-PDA-amMS methods, complementary in terms of polarity, was used to analyse
the broad spectrum of phytochemicals present in Filipendulae Ulmariae Herba. This
is a first step in the search for the active constituents of F. ulmaria .
Results and Discussion
Two generic LC-PDA-amMS methods were previously designed to be complementary in terms
of polarity: one method for moderately polar compounds such as phenolic constituents
[20 ] and another for apolar phytochemicals such as among others carotenoids and phytosterols
[21 ]. The current study is the first to combine both methods into a platform for comprehensive
phytochemical characterisation. A hybrid quadrupole-orbital trap MS analyser (Q Exactive™,
Thermo Fisher Scientific) was used, which enables selective ion fragmentation, a functionality
that contributes significantly to compound identification by generating clean product
ion spectra. Selective ion fragmentation is particularly useful for associating product
ions with precursor ions during coelution of multiple compounds, as is often the case
in complex plant extracts.
Although data-dependent fragmentation (ddMS2 ) provides vast amounts of structural information, in some cases, the generated product
ions may not suffice for full characterisation of the substructures (e.g., aglycon
moieties of flavonoid glycosides). In these cases, in-source collision-induced dissociation
(CID) fragmentation was used to generate substructure product ions in a first step.
These in-source product ions were subsequently selected with the quadrupole for higher
energy collisional dissociation (HCD) fragmentation to obtain pseudo MS3 spectra for their tentative identification.
Structures were assigned to unknown peaks only when both the mass/charge (m /z ) ratios and molecular formulae of the precursor and product ions were in agreement.
PDA spectra and retention times often provided additional confirmation of the proposed
structures. The information obtained by analysis is, however, not always sufficient
for peak identification at an acceptable confidence level. Additional information
for successful dereplication was often acquired from in-house and commercial compound
databases and peer reviewed publications. [Tables 1 ] and [2 ] show the diagnostic amMS and PDA data used for chromatographic peak identification.
These tables also specify the literature consulted for confirmation of compound identity.
Table 1 Chromatographic and spectral data of the (tentatively) identified compounds in F. ulmaria detected with a generic LC-PDA-amMS method for moderately polar phytochemicals. The
compound numbers match the data labels in [Fig. 1 ].
Compound number
Compound
Molecular formula
HESI neg full MSc
HESI neg ddMS2
HESI pos full MSd
HESI pos ddMS2
Retention time (min)
Maximum absorbance (nm)
Previously reported in literature
Plant part examined in literature
a Tentative identification based on accurate mass. b Identification with an analytical standard. c Deprotonated molecules unless stated otherwise. d Protonated molecules unless stated otherwise. e Broad peak. Italics : not found before in F. ulmaria . in: inflorescence, he: herba, ae: aerial part, le: leaves, ro: roots
1
sucrosea
C12 H22 O11
341.10893
179.1; 161.0; 143.0; 119.0
343.12349
–
1.5; 1.6
–
[10 ]
in
2
trehalosea
C12 H22 O11
341.10893
179.1; 161.0; 143.035; 119.0
343.12349
–
1.5; 1.6
–
[10 ]
in
3
gluconic acida
C6 H12 O7
195.05103
177.0; 159.0; 151.1; 141.0; 129.0
–
–
1.5
–
–
–
4
quinic acid
b
C7 H12 O6
191.05611
173.0; 127.0
–
–
1.6
–
–
–
5
quinic acid desoxyhexoside
a
C13 H24 O12
371.11950
327.1; 191.1; 163.1
–
–
1.6
–
–
–
6
monogalloylhexoside
a
C13 H16 O10
331.06707
211.0; 169.0
333.08162
315.1; 153.0
1.8; 2.2; 2.8; 3.6; 4.4
–
–
–
7
HHDP-hexoside isomers
a
C20 H18 O14
481.06238
301.0; 275.0; 257.0; 249.0; 229.0
483.07693
–
1.8; 2.4; 2.7; 2.9
–
–
–
8
malic acid
a
C4 H6 O5
133.01425
115.0; 89.0; 71.0
–
–
1.8
–
–
–
9
citric acid
a
C6 H8 O7
191.01973
173.0; 129.0; 111.0; 87.0; 85.0
–
–
2.1e
–
–
–
10
galloyl-threonic acid
a
C11 H12 O9
287.04086
169.0; 135.0
289.05541
–
3.5; 4.0; 5.9
–
–
–
11
phenylalanine
a
C9 H11 NO2
164.07170
147.0; 121.0
166.08626
149.1; 131.0; 120.1; 103.0
2.9
–
–
–
12
gallic acidb
C7 H6 O5
169.01425
125.0
–
–
4.3
268
[6 ], [7 ], [8 ], [9 ]
in
13
HHDP-monogalloyl-hexoside
a
C27 H22 O18
633.07334
301.0; 275.0; 257.0; 249.0; 169.0
635.08789
277.0; 259.0; 231.0; 153.0
5.1; 6.4; 7.1; 8.3
–
–
–
14
tryptophan
a
C11 H12 N2 O2
203.08260
–
205.09715
188.1; 170.1; 159.1; 146.1; 132.1; 118.1
5.2
–
–
–
15
2-pyrone-4,6-dicarboxylic acida
C7 H4 O6
182.99351
139.0
185.00806
–
5.5e
–
[42 ]
–
16
digalloylhexoside
a
C20 H20 O14
483.07803
331.1; 313.1; 211.0; 169.0
485.09258; 507.07453 [M + Na]+
467.1; 153.0
5.5; 6.9
–
–
–
17
protocatechuic acidb
C7 H6 O4
153.01933
109.0
–
–
6.5
259; 294
[6 ]
in
18
salicylic acid hexosidea
C13 H16 O8
299.07724
137.0; 93.0
323.07374 [M + Na]+ ; 318.11834 [M + NH4 ]+
–
6.7; 6.8
–
[24 ]
in; he
19
isosalicina
C13 H18 O7
285.09798
179.1; 161.0; 143.0
309.09447 [M + Na]+ ; 304.13908 [M + NH4 ]+
107.0
6.7
–
[25 ]
–
20
epigallocatechina
C15 H14 O7
305.06668
179.0; 137.0; 125.0
307.08123
163.0; 139.0
6.9
–
[9 ]
ae
21
pedunculagina
C34 H24 O22
783.06865
301.0; 275.0
785.08320
303.0; 277.0; 259.0; 231.0; 153.0
7.3, 8.5, 9.9
–
[3 ]
le
22
spiraeina
461.13006 [M – H + FA]− ; 415.12458
415.1; 293.1; 121.030; 93.0
439.12108 [M + Na]+ ; 434.16569 [M + NH4 ]+ ; 417.13914
295.1; 123.0
7.5
311
[8 ], [14 ]
in
23
syringic acida
C9 H10 O5
197.04555
181.0; 167.1; 153.0; 125.0
–
–
7.7
–
[9 ]
ae
24
caffeoyl-threonic acid
a
C13 H14 O8
297.06159
179.0; 135.0
299.07614
163.0; 145.0; 135.0
7.8, 8.2, 9.7
–
–
–
25
methyl gallate
a
C8 H8 O5
183.02990; 367.06707 [2 M – H]−
168.0; 124.0
185.04445
153.0
7.9
272
–
–
26
kuromanin
b
[C21 H21 O11 ]+
447.09328
284.0; 285.0; 255.0
449.10784
287.1
8
279; 517
–
–
27
keracyanin
b
[C27 H31 O15 ]+
593.15119
–
595.16575
287.1
8.2
280; 517
–
–
28
procyanidin dimer
a
C30 H26 O12
577.13515
425.1; 407.1; 289.1; 245.1
579.14970
427.1; 409.1; 291.1; 289.1; 287.1
8.7, 8.9, 9.2, 9.9, 10.8, 11.4
–
–
–
29
catechinb
C15 H14 O6
289.07176
245.1; 205.0; 137.0
291.08741
139.0; 123.0
8.9
279
[9 ]
ae
30
aesculetina
C9 H6 O4
177.01933
133.0; 105.0; 89.0
179.03389
149.0
9
–
[7 ]
ae
31
monotropitina
C19 H26 O12
491.14063 [M – H + FA]− ; 445.13515
445.1; 293.1; 151.0; 137.0
469.13165 [M + Na]+ ; 464.17625 [M + NH4 ]+
295.1; 153.1
9
–
[5 ], [14 ], [25 ]
–
32
chlorogenic acidb
C16 H18 O9
353.08781
351.1; 191.1
355.10236
163.0
9.2
326
[7 ]
ae
33
coumaroylthreonic acid
a
C13 H14 O7
281.06668
193.0; 163.0; 135.0; 119.0
283.08123
147.0; 119.0
9.2, 9.7, 11.1, 11.5
–
–
–
34
trigalloylhexoside
a
C27 H24 O18
635.08899
483.1; 465.1; 423.1; 313.1; 271.1; 211.0; 193.0; 169.0; 125.0
637.10354
619.1; 153.0
9.4; 9.5; 9.8; 10.0; 10.7; 10.9; 11.1
–
–
–
35
procyanidin trimer
a
C45 H38 O18
865.19854
575.1; 407.1; 289.1; 287.1; 245.0; 243.0
867.21309
577.1; 409.1; 247.1; 245.0
9.7, 9.9, 10.6, 11.0, 11.3, 11.5, 12.0
–
–
–
36
procyanidin tetramer
a
C60 H50 O24
1153.26193; 576.12732 [M – 2 H]2-
863.2; 575.1; 407.1; 289.1; 287.1; 245.0; 243.0
1,155.27648
867.2; 577.1; 409.1; 247.1; 245.0
9.7, 10.2, 10.6, 11.3, 11.5, 11.8
–
–
–
37
epicatechinb
C15 H14 O6
289.07176
245.1; 205.1; 137.0
–
–
9.8
280
[9 ]
ae
38
3,4-dihydroxycinnamic acidb
C9 H8 O4
179.03498
135.0
181.04954
163.0
9.9
–
[7 ], [9 ]
ae
39
procyanidin B2b
C30 H26 O12
577.13515
425.1; 407.1; 289.1; 245.1
579.14970
427.1; 409.1; 291.1; 289.1; 287.1
9.9
–
[9 ]
ae
40
procyanidin pentamer
a
C75 H62 O30
1441.32531; 720.15902 [M – 2 H]2-
1151.2; 863.2; 575.1; 407.1; 289.1; 287.1; 245.0; 243.0
1443.33987; 722.17357 [M + 2 H]2+
–
9.9; 10.8; 11.0; 11.3; 11.7; 11.9; 12.2; 12.4
–
–
–
41
(epi)catechin coupled to C15 H14 O5
a
C30 H26 O11
561.14023
435.1; 425.1; 407.1; 289.1; 273.1; 271.1; 245.1
563.15479
409.1; 299.1; 291.1; 289.1; 287.1; 275.1; 257.0; 231.1; 179.0; 147.0
9.9, 10.3, 10.9, 12.1
–
–
–
42
rugosin Ba
C41 H30 O27
953.09017
909.1; 785.1; 766.1; 597.0; 301.0; 275.0; 249.0; 169.0
955.10472
785.1; 467.1; 453.0; 427.0; 261.0; 153.0
10.0, 10.7, 11.1
–
[3 ], [6 ], [9 ]
in
43
tellimagrandin Ia
C34 H26 O22
785.08430
301.0; 275.0; 249.0; 169.0
787.09885
277.0; 259.0; 231.0; 153.0
10.5
–
[3 ], [6 ], [8 ], [9 ]
in
44
coumaroylquinic acid
a
C16 H18 O8
337.09289
191.1
339.10744; 361.08939 [M + Na]+
165.1; 147.0
10.6; 10.8
–
–
–
45
procyanidin hexamer
a
C90 H74 O36
864.19071 [M – 2 H]2-
–
–
–
11.5; 12.2
–
–
–
46
quercetin-O-dihexosidea
C27 H30 O17
625.14102
463.1; 301.0; 271.0; 255.0; 179.0; 151.0
627.15558
465.1; 303.0; 153.0
11.4
[9 ]
ae
47
procyanidin dimer gallate
a
C37 H30 O16
729.14611
577.1; 407.1; 289.1; 245.0; 243.0; 169.0
731.16066
411.1; 287.1; 271.1; 259.1; 247.1; 153.0
11.4
–
–
–
48
casuarinin/casuarictina
C41 H28 O26
935.07960
785.1; 633.1; 483.1; 451.0; 425.0; 301.0; 275.0; 169.0
937.09416
767.1; 467.1; 453.0; 427.0; 153.0
11.8, 12.6, 12.8
–
[3 ]
le
49
procyanidin heptamer
a
C105 H86 O42
1008.22241 [M – 2 H]2-
–
–
–
11.8; 12.6
–
–
–
50
rugosin Ea
C75 H54 O48
860.08195 [M – 2 H]2-
937.1; 785.1; 597.0; 301.0; 275.0; 249.0; 169.0
–
–
11.9, 12.3, 12.5, 12.8
–
[3 ], [6 ], [9 ]
in
51
tetragalloylglucose
b
C34 H28 O22
787.09995
635.1; 617.1; 465.1; 447.1; 313.1; 295.0; 169.0
811.09644
–
12.2; 12.4; 12.6
–
–
–
52
rugosin Aa
C48 H34 O31
1105.10113; 552.04693 [M – 2 H]2-
530.0; 891.1; 301.0; 169.0
–
–
12.2
–
[3 ], [6 ], [9 ]
in
53
tellimagrandin IIa
C41 H30 O26
937.09525
301.0; 275.0; 249.0; 169.0
–
–
12.2
–
[3 ], [6 ], [8 ], [9 ]
in
54
p-coumaric acidb
C9 H8 O3
163.04007
119.0
165.05462
–
12.2
–
[9 ]
ae
55
rutinb
C27 H30 O16
609.14611
300.0; 271.0; 255.0; 243.0
611.16066
465.1; 303.0
12.4
256; 355
[6 ], [7 ], [9 ]
in
56
galloyl-caffeoyl-threonic acid
a
C20 H18 O12
449.07255
297.1; 287.0; 179.0; 169.0; 135.0
451.08710
287.1; 163.0; 153.0; 145.0; 135.0
12.6
–
–
–
57
procyanidin octamer
a
C120 H98 O48
1152.25410 [M – 2 H]2-
–
–
–
12.6
–
–
–
58
ellagic acidb
C14 H6 O8
300.99899
284.0; 257.0; 229.0; 201.0; 185.0
–
–
12.8
367
[9 ]
ae
59
hyperosideb
C21 H20 O12
463.08820
300.0; 271.0; 255.0; 243.0; 151.0
465.10275
303.0
12.9
256; 352
[6 ], [9 ]
in
60
isoquercitrinb
C21 H20 O12
463.08820
300.0; 271.0; 255.0; 243.0; 151.0
465.10275
303.0
12.9
256; 352
[4 ], [6 ], [7 ], [9 ]
in; ae
61
rugosin Da
C82 H58 O52
936.08743 [M – 2 H]2-
1061.1; 917.1; 851.1; 767.1; 749.1; 465.1; 301.0; 275.0; 249.0; 169.0
–
–
12.9
–
[3 ], [6 ], [9 ]
in
62
quercetin-O-galloyldihexoside
a
C34 H34 O20
761.15707
301.0; 271.0; 255.0; 243.0; 227.0; 179.0; 151.0; 121.0; 107.0
763.17162
617.1; 461.1; 315.1; 303.0; 285.0; 257.0; 229.0; 201.1; 165.0; 163.0; 153.0; 149.0;
137.0
13
258; 351
–
–
63
azelaic acid
a
C9 H16 O4
187.09758
169.1; 143.1; 125.1
–
–
13
–
–
–
64
isorhamnetin-O-hexosidea
C22 H22 O12
477.10385
314.0; 299.0; 285.0; 271.0; 243.0; 169.0
479.11840
317.1; 302.0
13.1; 13.7
–
[8 ]
in
65
cinchonain Ib and/or Ia
a
C24 H20 O9
451.10346
341.1; 299.1; 231.0; 217.0; 189.0; 177.0
453.11801
411.1; 343.1; 317.1; 313.1; 301.1; 271.1; 259.1
13.1; 13.3
–
–
–
66
pentagalloylglucose
b
C41 H32 O26
939.11090
769.1; 617.1; 465.1; 447.1; 295.0; 169.0
963.10740
–
13.2
–
–
–
67
methoxyflavonoid-O-hexoside-deoxyhexoside
a
C28 H32 O15
607.16684
298.0; 283.0
609.18140
463.1; 301.1; 286.0
13.2
–
–
–
68
kaempferol-O-hexoside-deoxyhexosidea
C27 H30 O15
593.15119
285.0; 255.0; 169.0
595.16575
449.1; 287.1
13.2
–
[6 ], [9 ]
in
69
quercetin-O-galloylhexoside
a
C28 H24 O16
615.09916
313.1; 301.0; 271.0; 255.0; 243.0; 227.0; 179.0; 151.0; 121.0; 107.0
617.14071
315.1; 303.0; 257.0; 229.0; 201.1; 165.0; 163.0; 153.0; 149.0; 137.0
13.2; 13.3
–
–
–
70
miquelianinb
C21 H18 O13
477.06746
301.0; 271.0; 255.0; 179.0; 151.0
479.08202
303.0; 257.0
13.3
257; 357
[9 ]
ae
71
quercetin-O-pentoside
a
C20 H18 O11
433.07763
301.0; 300.0; 271.0; 255.0; 243.0; 179.0; 151.0
435.09219
303.0; 285.0; 257.0; 229.0; 201.1; 165.0; 163.0; 153.0; 149.0; 137.0
13.5
–
–
–
72
avicularin/avicularosideb
C20 H18 O11
433.07763
301.0; 300.0; 271.0; 255.0; 243.0; 179.0; 151.0
435.09219
303.0
13.6
256; 355
[4 ], [7 ], [9 ]
ae
73
astragalinb
C21 H20 O11
447.09328
284.0; 255.0; 227.0
449.10784
287.1
13.6
265; 348
[6 ], [9 ]
in; ae
74
quercetin-O-digalloylhexoside
a
C35 H28 O20
767.11012
615.1; 465.1; 313.1; 301.0; 169.0; 125.0; 271.0; 255.0; 243.0; 227.0; 179.0; 151.0;
121.0; 107.0
769.12467
467.1; 303.0; 285.0; 257.0; 229.0; 201.1; 165.0; 163.0; 153.0; 149.0; 137.0
13.7; 13.8; 14.0
–
–
–
75
di-O-caffeylquinic acida
C25 H24 O12
515.11950
447.1; 353.1; 191.1; 179.0; 135.0
517.13405
–
13.7, 13.8 and 14.1
–
[9 ]
ae
76
methyl caffeate
a
C10 H10 O4
193.05063
178.0; 161.0; 134.0
195.06519
163.0; 145.0; 135.0
13.8
–
–
–
77
quercitrinb
C21 H20 O11
447.09328
300.0; 285.0; 271.0; 255.0; 243.0
449.10784
303.0; 287.1
13.8
265; 346
[6 ], [9 ]
in
78
quercetin-O-hexosidea
C21 H20 O12
463.08820
301.0; 179.0; 151.0
465.10275
377.0; 359.0; 303.0; 287.1; 177.1; 153.0
13.9
–
[6 ], [7 ], [8 ], [9 ]
in
79
flavonoid-O-galloylhexoside
a
C28 H24 O15
599.10424
463.1; 313.1; 301.0; 285.0
601.11880
315.1; 287.1; 153.0
14
–
–
–
80
salicylic acidb
C7 H6 O3
137.02442
93.0
–
–
14
236; 302
[5 ], [6 ], [7 ], [9 ]
in
81
kaempferol-O-hexosidea
C21 H20 O11
447.09328
284.0; 227.0; 151.0
449.10784
–
14.1
–
[6 ], [9 ]
in
82
deoxy-cinchonain Ia and/or Ib
a
C24 H20 O8
435.10854
341.1; 231.0; 217.0; 189.0; 177.0
437.12309
395.1; 343.1; 317.1; 285.1; 243.1; 191.0
14.2; 14.3
–
–
–
83
digalloyl-caffeoyl-threonic acid
a
C27 H22 O16
601.08351
449.1; 297.1; 287.0; 179.0; 169.0; 135.0
603.09806
423.1 253.0; 163.0; 153.0; 145.0; 135.0
14.2
–
–
–
84
methoxyflavonoid-O-hexoside-deoxyhexoside
a
C28 H32 O14
637.17741 [M – H + FA]− ; 591.17193
591.2; 283.1; 268.0
593.18648
447.1; 285.1; 270.0
14.5
270; 332
–
–
85
aromadendrin
b
C15 H12 O6
287.05611
259.1; 243.1; 215.1; 201.1; 177.1; 151.0; 125.0
289.07066
–
14.5
–
–
–
86
dimethoxyflavonoid-O-hexoside-deoxyhexoside
a
C29 H34 O15
667.18797 [M – H + FA]-; 621.18249
621.2; 313.1; 298.0; 283.0
623.19705
477.1; 315.1; 300.1
14.5
270; 332
–
–
87
sebacic acid
a
C10 H18 O4
201.11323
183.1; 139.1
–
–
14.8
–
–
–
88
trigalloyl-caffeoyl-threonic acid
a
C34 H26 O20
753.09447
601.1; 449.1; 297.1; 287.0; 179.0; 169.0; 135.0
755.10902
–
14.9
–
–
–
89
digalloyl-coumaroyl-threonic acid
a
C27 H22 O15
585.08859
433.1; 281.1; 169.0; 163.0; 135.0
587.10424
423.1; 153.0; 147.0
15.1
–
–
–
90
quercetin-O-galloyldeoxyhexoside
a
C28 H24 O15
599.10424
301.0; 271.0; 255.0; 243.0; 227.0; 179.0; 169.0; 151.0; 121.0; 107.0
601.11880
303.0; 257.0; 229.0; 153.018
15.3
–
–
–
91
eriodictyol
b
C15 H12 O6
287.05611
151.0; 135.0; 125.0
289.07066
163.0; 153.0; 145.0; 135.0; 123.0
15.4
–
–
–
92
protocatechuic acid-salicyl-hexoside
a
C20 H20 O11
435.09328
315.1; 297.1; 153.0; 137.0; 109.0
–
–
15.4; 16.0
–
–
–
93
trihydroxyoctadecadienoic acid
a
C18 H32 O5
327.21770
291.2; 239.1; 229.1; 193.1; 171.1
–
–
15.9
–
–
–
94
tormentosidea
C36 H58 O10
649.39572; 487.34290 [M – H – sugar]−
–
489.35745 [M + H – sugar]+
471.3; 453.3; 435.3; 425.3; 407.3; 201.2; 207.2; 205.2; 189.2; 187.2
16.1; 17.2
–
[11 ]
–
95
luteolin
b
C15 H10 O6
285.04046
199.0; 151.0; 133.0
287.05501
153.0 135.0
16.4
–
–
–
96
quercetinb
C15 H10 O7
301.03538
271.0; 245.0; 193.0; 179.0; 151.0; 121.0; 107.0
303.04993
285.0; 257.0; 229.0; 201.1; 165.0; 163.0; 153.0; 149.0; 137.0
16.5
255; 372
[6 ], [7 ], [9 ]
in
97
phloretin
b
C15 H14 O5
273.07685
167.0; 151.0; 123.0; 119.0
275.09140
–
16.8
–
–
–
98
naringenin
b
C15 H12 O5
271.06120
253.0; 227.1; 177.0; 151.0; 119.0
273.07575
153.0; 147.0; 119.0; 107.0
16.9
–
–
–
99
methoxyflavonoid
a
C16 H12 O6
299.05611
284.0; 271.0; 151.0; 179.1
301.07066
286.0; 258.0
17.6
–
–
–
100
apigeninb
C15 H10 O5
269.04555
225.1; 151.0
271.06010
17.8
–
[9 ]
ae
101
isorhamnetin
b
C16 H12 O7
315.05103
300.0; 151.0
317.06558
302.0; 285.0; 153.0
17.9
–
–
–
102
kaempferolb
C15 H10 O6
285.04046
–
287.05501
258.0; 241.0; 231.1; 165.0; 153.0; 137.0; 121.0
18.1
265; 364
[6 ], [7 ], [9 ]
in
103
dimethoxyflavonoid
a
C17 H14 O6
–
–
315.08631
300.1; 168.0
19.4
–
–
–
104
methoxyflavonoid
a
C16 H12 O5
283.06120
268.0
285.07575
270.0; 242.1
19.5
–
–
–
105
galangin
b
C15 H10 O5
269.04555
–
271.06010
–
20
–
–
–
106
ursolic acida
C30 H48 O3
455.35307
–
457.36762
439.4; 411.4; 393.4; 203.2; 191.2; 189.2; 187.2
20.3
–
[11 ]
ro
107
tormentic acid
a
C30 H48 O5
487.34290
–
489.35745
471.4; 453.3; 435.3; 425.3; 407.3; 201.2; 205.2; 189.2; 187.2
20.5
–
–
–
108
pomolic acida
C30 H48 O4
471.34798
–
473.36254
455.4; 437.3; 201.2; 191.2
21.6
–
[11 ]
ro
Fig. 1 Plot of the retention times vs. m /z values of the compounds identified in F. ulmaria detected with a generic LC-PDA-amMS method for moderately polar phytochemicals. The
data labels match the compound numbers in [Table 1 ].
Table 2 Chromatographic and spectral data of the (tentatively) identified compounds in F. ulmaria detected with a generic LC-PDA-amMS method for apolar phytochemicals.
Compund number
Compound
Molecular formula
HESI neg full MSc
HESI neg ddMS2
HESI pos full MSd
HESI pos ddMS2
Retention time (min)
Maximum absorbance (nm)
Previously reported in literature
Plant part examined in literature
a Tentative identification based on accurate mass. b Identification with an analytical standard. c Deprotonated molecules unless stated otherwise. d Protonated molecules unless stated otherwise. Italics : detected and not reported in F. ulmaria before. in: inflorescence
109
cis- and trans-violaxanthin
b
C40 H56 O4
–
–
601.42514
–
6.9; 7.1
418; 442; 472
–
–
110
Lutein
b
C40 H56 O2
–
–
569.43531; 551.42474 [M + H – H2 O]+ ; 533.41418 [M + H – 2H2 O]+
–
10.1
430; 455; 482
–
–
111
dihydroxychlorophyll a and a ′a
C55 H70 O7 N4 Mg
981.52334 [M – H + FA]− ; 921.50222
642.2; 584.2; 569.2
945.49871 [M + Na]+ ; 923.51677
–
11.4; 11.5
460; 649
–
–
112
chlorophyll b and b′a
C55 H70 O6 N4 Mg
965.52843 [M – H + FA]− ; 905.50730
626.2; 555.2; 540.2
907.51783
879.5; 629.2; 597.2; 569.2; 541.2
12.0; 12.6
461; 645
[10 ]
in
113
hydroxychlorophyll a or a ′a
C55 H72 O6 N4 Mg
967.54408 [M – H + FA]− ; 907.52295
849.5; 628.2; 570.2; 555.2
931.51945 [M + Na]+
–
12.9
427; 662
–
–
114
chlorophyll a and a'a
C55 H72 O5 N4 Mg
951.54917 [M – H + FA]− ; 891.52804
612.2; 541.2; 526.2
915.52453 [M + Na]+ ; 893.54259
833.5; 614.2; 583.2; 555.2
13.4; 13.8
431; 617; 663
[10 ]
in
115
campesterol
b
C28 H48 O
–
–
383.36723 [M + H – H2 O]+
–
15.3
–
–
–
116
phaeophytin b and b ′a
C55 H72 N4 O6
883.53791
533.2; 518.2
885.55246
607.3; 579.3; 547.2
15.5
436; 653
–
–
117
β-sitosterol
b
C29 H50 O
–
–
397.38288 [M + H – H2 O]+
–
15.8
–
–
–
118
phaeophytin a and a ′a
C55 H74 N4 05
869.55864
519.2; 504.2
893.55514 [M + Na]+ ; 871.57320
593.3; 533.3
16.5; 16.9
408; 664
–
–
119
cis - and trans -isomers of β -caroteneb
C40 H56
–
–
537.44548
445.38288
16.6; 16.7; 17.1
430; 455; 482
[10 ]
in
Application of a generic LC-PDA-amMS method for the identification of moderately polar
phytochemicals enabled the identification of a multitude of phenolic constituents,
many of which have never been reported before in F. ulmaria . Compounds identified for the first time in F. ulmaria are indicated in italics in [Tables 1 ] and [2 ]. [Fig. 1 ] provides an overview of the retention times and m /z values in the heated electrospray ionisation (HESI) negative mode of the compounds
identified with this method. The data labels match the compound numbers in [Table 1 ]. Predominantly deprotonated molecules ([M – H]− ) were formed in the negative ionisation mode. Formic acid adducts ([M – H + FA]− ), deprotonated dimers ([2 M – H]− ), doubly deprotonated molecules ([M – 2 H]2− ) and product ions caused by in-source fragmentation were also observed ([Table 1 ]). In the positive ionisation mode, predominantly protonated molecules ([M + H]+ ) were generated and, to a lesser extent, also sodium adducts, ammonium adducts, doubly
protonated molecules ([M + Na]+ , [M + NH4 ]+ , [M + 2 H]2+ , respectively), and product ions caused by in-source fragmentation ([Table 1 ]).
Flavonoids chiefly occurred as glycoconjugates (with hexose, pentose, deoxyhexose,
dihexose, and hexose-deoxyhexose moieties; [Table 1 ]). Several of the glycosides were identified with analytical standards. Other flavonoid
glycoconjugates were identified with ddMS2 : HCD fragmentation resulted in the distinct presence of product ions caused by the
loss of sugar moieties, indicating glycosidic O-linkages [22 ]. Various glycosyl flavonoids acylated with (di)galloyl moieties were also detected.
In-source CID fragmentation and subsequent HCD fragmentation of the aglycon moiety
(pseudo MS3 ) often allowed for the tentative identification of the flavonoid moieties. Fragmentation
of flavonoid aglycons has been reviewed in detail previously, among others by Cuyckens
and Claeys [22 ]. The main flavonoid moieties of the detected glycosides consisted of quercetin and
kaempferol, in line with previous studies [6 ], [9 ]. Multiple flavonoid aglycons were found, such as among others quercetin, kaempferol,
catechin, epicatechin, epigallocatechin, apigenin, isorhamnetin, and luteolin. Several
flavonoids that were previously reported (e.g., ulmarioside, epigallocatechingallate,
and isorhamnetin acetylhexoside) were not detected, which is probably due to natural
phytochemical variations in between plants and plant parts examined [8 ], [9 ] or due to a difference in method/instrument sensitivity. Nevertheless, various flavonoid
aglycons and glycoconjugates, of which several have never been described in F. ulmaria before (indicated in italics in [Table 1 ]), have been identified during the current study.
Some phenolic acids such as gallic acid, protocatechuic acid, syringic acid and salicylic
acid, and hydroxycinnamic acids such as caffeic acid and p-coumaric acid were detected
in the free form ([Table 1 ]), in agreement with previous studies [5 ], [9 ]. All free phenolic and hydroxycinnamic acids except syringic acid were identified
with analytical standards. The product ions of syringic acid generated by ddMS2 matched with those described by Sun et al. [23 ]. Glycosylated salicyl derivatives (salicylic acid hexoside, isosalicin, monotropitin,
and spiraein) were also present, while methyl salicylate, salicyl alcohol, and salicyl
aldehyde, previously reported in F. ulmaria , were not found [5 ], [14 ], [24 ], [25 ]. Next to salicylates, a rich diversity of phenolic and hydroxycinnamic acid oligomers
was detected, most of which have never been reported before in F. ulmaria (indicated in italics in [Table 1 ]). Tentative identification of these oligomers was based on the consecutive loss
of phenolic monomer units during ddMS2 ([Table 1 ]) [26 ]. The phenolic oligomers consisted predominantly of structures containing galloyl,
caffeoyl, quinoyl, and coumaroyl moieties. Several phenolic acid and hydroxycinnamic
acid oligomers were also detected as glycoconjugates. Often multiple chromatographic
peaks were found for the same precursor ion, indicating the presence of structural
isomers due to different linkage sites and/or different sugar moieties.
Several of the tentatively identified oligomeric phenolic acid structures described
in the previous section may be classified as gallotannins (hydrolysable tannins) [27 ]. Some of these gallotannins are metabolic precursors of ellagitannins in plants
(e.g., pentagalloylglucose is a precursors of tellimagrandin II) [26 ], [28 ]. F. ulmaria has been described as a rich source of various monomeric ellagitannins such as casuarinin,
casuarictin, pedunculagin, tellimagrandins I and II, rugosins A and B. and dimeric
ellagitannins rugosins D and E [3 ], [6 ], [8 ], [9 ]. Such hydrolysable tannins consist of one or more hexahydroxydiphenic acid (HHDP)
moieties and several galloyl and glucose moieties [3 ], [6 ]. During the current study, ionisation of dimeric rugosins resulted in significant
amounts of [M – 2 H]2- ions ([Table 1 ]). The fragmentation patterns of the ellagitannins were characterised by consecutive
losses of monomeric units ([Table 1 ]). Next to previously reported hydrolysable tannins, other ellagitannins were also
tentatively identified during this study (indicated in italics in [Table 1 ]); several HHDP-monogalloyl-hexoside and HHDP-hexoside isomers, similar to the structures
of tellimagrandins, were detected. Ellagic acid, which may be formed by hydrolysis
of ellagitannins and occurs in multiple plants, fruits, and nuts, was also identified
during this study using an analytical standard [29 ].
Only one recent study has investigated the presence of procyanidins in F. ulmaria . Olennikov and Kruglova detected procyanidins B1 and B2 [9 ]. During the current study, a multitude of procyanidins ranging from dimeric to octameric
isomers was tentatively identified. Procyandin dimer gallate was also tentatively
identified. The fragmentation pattern of the detected procyanidins obtained with ddMS2 corresponded to that of an analytical standard solution of procyanidin B2 and is
in accordance with their fragmentation described by Regueiro et al. [26 ]. Increasing amounts of [M – 2 H]2- ions were observed with increasing procyanidin mass, starting from tetramers. For
hexamers, heptamers, and octamers, only the [M – 2 H]2− ion was observed. Because of the low abundant [M – 2 H]2− signals of the procyanidin hexamers, heptamers, and octamers, selective fragmentation
could not be used to confirm their identity. Nontheless, the use of a hybrid orbitrap
mass analyser enabled the tentative identification of a large amount of tannins that
have never been reported before in F. ulmaria (indicated in italics in [Table 1 ]).
Based on the most abundant signals observed with PDA detection, the main phenolic
constituents of Filipendulae Ulmariae Herba were identified: gallic acid (12 ), procyanidin dimer (28 ; not B2), rugosin A (52 ) or tellimagrandin II (53 ), rutin (55 ), hyperoside (59 ), isoquercitrin (60 ), quercetin-O-galloyldihexoside (62 ), kaempferol-O-hexoside-deoxyhexoside (68 ), quercetin-O-galloylhexoside (69 ), quercetin-O-pentoside (71 ), avicularoside (72 ), astragalin (73 ), quercetin-O-hexoside (78 ), digalloyl-caffeoyl-threonic acid (83 ), methoxyflavonoid-O-hexoside-deoxyhexoside (84 ), dimethoxyflavonoid-O-hexoside-deoxyhexoside (86 ), digalloyl-coumaroyl-threonic acid (89 ), and quercetin (96 ). These results show that the main constituents predominantly consist of flavonoid
glycosides and tannins. Compounds for which a reference standard was available were
quantified with LC-amMS ([Table 3 ]). The concentrations detected during this study are in accordance with those found
by Fecka, who investigated the concentration of selected polyphenols in dried flowers
of F. ulmaria . [6 ].
Table 3 Concentrations of phenolic constituents in Filipendulae Ulmariae Herba in µg/g, calculated
with reference standards using LC-amMS. The measurement uncertainties are expressed
as the standard deviation of three replicates.
Quinic acid
Gallic acid
Protocatechuic acid
Kuromanin
Catechin
Chlorogenic acid
Epicathecin
Caffeic acid
Procyanidin B2
p-coumaric acid
Rutin
Ellagic acid
Hyperin
Isoquercitrin
Astragalin
Salicylic acid
Quercitrin
Quercetin
Kaempferol
Concentration (µg/g)
1800 ± 100
1340 ± 70
74 ± 3
122 ± 5
1900 ± 100
640 ± 10
83 ± 4
47 ± 2
144 ± 6
31 ± 1
3100 ± 200
1540 ± 60
4400 ± 200
530 ± 40
99 ± 1
630 ± 20
215 ± 5
1040 ± 40
64 ± 3
Consistent with previous literature, only few and frequently low abundant non-phenolic
phytochemicals were detected in Filipendulae Ulmariae Herba. Some triterpenes were
tentatively identified with the generic LC-PDA-amMS method for moderately polar phytochemicals,
while chlorophyll derivatives, phytosterols, and carotenoids were detected with the
complementary LC-PDA-amMS method for apolar phytochemicals. Ionisation in the negative
and positive modes during analysis with the LC-PDA-amMS method for apolar phytochemicals
predominantly rendered [M – H]− and [M – H + FA]− ions and [M + H]+ and [M + Na]+ ions, respectively. Product ions due to in-source fragmentation (e.g., loss of water
and sugar moieties) were also observed ([Table 2 ]).
Ursolic acid, pomolic acid, and tormentoside, a glycoside of tormentic acid, have
been described to be present in the roots of F. ulmaria [11 ]. During this study, these compounds were also tentatively identified based on product
ions formed by selective HCD fragmentation in positive ionisation mode ([Table 1 ]). Formation of product ions by retro Diels-Alder fragmentation according to the
fragmentation proposed by Li et al. was observed for all triterpenes [30 ]. Consecutive losses of water and CO2 moieties (and a sugar moiety for tormentoside) were also detected. Two chromatographic
peaks were detected for tormentoside, indicating the presence of two isomers. Next
to the previously reported triterpenes, tormentic acid was tentatively identified
for the first time in F. ulmaria during the current study, with a fragmentation pattern similar to the other triterpene
aglycons ([Table 1 ]).
Barros et al. reported the presence of chlorophylls a and b in F. ulmaria [10 ]. These compounds were also tentatively identified based on their MS fragmentation
spectra and UV absorbance maxima. Two chromatographic peaks were observed for the
respective chlorophylls, corresponding to chlorophyll epimers a and a ʼ and b and b ʼ [31 ]. Moreover, other chlorophyll derivatives, such as phaeophytins, hydroxychlorophylls
and dihydroxychlorophylls, were also detected, compounds that have not been reported
before in F. ulmaria ([Table 2 ]).
Although only present in low amounts, two phytosterols (campesterol and β -sitosterol) that have not been described previously in F. ulmaria were identified with analytical standards ([Table 2 ]). Both phytosterols were characterised by abundant [M + H – H2 O]+ ions due to in-source fragmentation. These main [M + H – H2 O]+ ions of both phytosterols appeared at several retention times throughout the chromatogram
(data not shown). Application of the same LC-PDA-amMS method in a former study has
shown that the main in-source produced ion of a free sterol is also the main detected
ion of its derivatives, i.e., acylated sterols, steryl glycosides and acylated steryl
glycosides, generated by the loss of the attached sugar/fatty acid moieties due to
in-source fragmentation [21 ]. The deprotonated molecules of the derivatives usually are detected in the negative
ionisation mode, thereby revealing the identity of the attached sugar and/or fatty
acid. Due to their low abundances, they could, however, not be detected during the
present study.
Carotenoids have only been scarcely investigated in F. ulmaria ; Barros et al. has reported the presence of lycopene and β -carotene in inflosescences [10 ]. Lycopene was not detected during the current study. Small amounts of β -carotene, lutein, and violaxanthin were, however, identified with analytical standards
([Table 2 ]).
Barros et al. identified tocopherols in inflorescences of F. ulmaria , but they were not detected during this study [10 ]. Other compounds such as organic acids, amino acids, free sugars, and lipids (data
not shown) were tentatively identified with the LC-PDA-amMS platform. Although these
findings are interesting from an analytical perspective, the biological functions
of these compounds are known and no direct contribution to the specific pharmacological
activity of F. ulmaria is expected.
Salicylic acid, the in vivo metabolite of salicylic alcohol derivatives, is responsible for part of the pharmacological
activity of F. ulmaria [5 ], [13 ]. During the current study, several metabolic precursors of salicylic acid were detected.
However, a large diversity of other phytochemicals were identified that are likely
to contribute as well to the activity of F. ulmaria . In view of the phenolic nature of the main constituents, extensive metabolisation
after oral intake before absorption can be expected. It has been estimated that more
than 90 % of ingested polyphenols are not absorbed in the small intestine and, thus,
remain in the colon at a high concentration where they are extensively metabolised
by gut microbiota to produce smaller molecules [32 ].
In the human gastrointestinal tract, ingested dietary ellagitannins are hydrolysed
to release ellagic acid and further metabolised by the colon microbiota to produce
dibenzopyranones known as urolithin derivatives (less potent antioxidants as they
have lost their free-radical scavenging activity) [27 ], [29 ]. Urolithins appear in human systemic circulation within a few hours after consumption
[29 ]. Ellagitannin, ellagic acid, and derived metabolites have antioxidant functions,
estrogenic and/or antiestrogenic activities, and anti-inflammatory and prebiotic effects
[29 ]. A five-week supplementation of pomegranate juice or pomegranate fruit extract in
obese Zucker rats fed an atherogenic diet, for instance, showed a significant decrease
in the expression of vascular inflammation markers [33 ].
Procyanidins have been shown to mediate several anti-inflammatory mechanisms involved
in the development of cardiovascular disease [34 ]. Although there is no consensus on the absorption and metabolism of procyanidins
thus far, they seem to be poorly absorbed in the gut due to their polymeric nature
and high molecular weight [32 ]. A possible degradation into flavan-3-ols and low molecular weight products such
as phenolic acids and valerolactones can be an explanation for the health effect of
procyanidins [32 ], [35 ]. These low molecular weight phenolic compounds can be absorbed more readily [35 ].
Flavonoid intake is negatively correlated with the incidence of several chronic diseases
including cardiovascular diseases, type II diabetes, neurodegenerative diseases, and
cancers [12 ], [36 ]. As described by Hollman, flavonoid glucosides are generally the only glycosides
that can be absorbed from the small intestine. After absorption from the small intestine,
flavonoids are conjugated with glucuronic acid, sulphate, or O-methylation and, as
a result, no free flavonoid aglycones can be found in plasma or urine, except for
catechins. Flavonoids that cannot be absorbed from the small intestine will be degraded
in the colon by microorganisms, which will break down the flavonoid ring structure.
The resulting phenolic acids can be absorbed and have been measured in plasma and
urine [37 ].
Phenolic acids are extensively studied due to their bioactive properties and there
is evidence of their role in disease prevention [38 ]. Like other phenolic compounds they are extensively metabolised and circulate in
the organism as glucuronated, sulphated, and methylated metabolites, displaying different
bioactivities compared to their precursors [38 ]. Likewise, hydroxycinnamic acids, naturally occurring anti-inflammatory bioactive
compounds, are also extensively metabolised [39 ].
A versatile range of phytochemicals that were tentatively identified during this study
are reported to be beneficial for human health. F. ulmaria or extracts thereof may therefore be considered as a promising source for future
functional ingredients. However, all the findings on the extensive metabolisation
of phenolic constituents urge the need for a shift of (poly)phenol research towards
intestinal, colonic, and hepatic metabolites as the principal bioactives [12 ], [38 ], [39 ]. Although the exact structure of the phenolic constituents identified during this
study (e.g., the nature of the sugars and the interglycosidic linkages of glycosides)
often cannot be established with LC-amMS without reference standards, these linkages
are frequently broken during metabolisation. Comprehensive and fast LC-amMS profiling
should be combined with pharmacological evaluation of plant extracts before and after
metabolisation to enable the identification of potential pro-drugs that otherwise
may be overlooked.
Next to phenolic compounds, only few and often low abundant non-phenolic phytochemicals
were detected in Filipendulae Ulmariae Herba. Several triterpenes were tentatively
identified. Ursolic and pomolic acid were previously identified by Halkes as being
the major compounds in the roots of F. ulmaria inhibiting T-lymphocyte proliferation [11 ]. Ursolic acid belongs to the pentacyclic triterpenes class of compounds, which is
widely distributed in the plant kingdom and is primarily responsible for the anti-inflammatory
activity of a variety of medicinal plants [40 ].
The chlorophyll derivatives, phytosterols, and carotenoids detected in low abundance
during this study are ubiquitously present in nature and no relevant contribution
to the specific pharmacological activity of F. ulmaria is expected.
In conclusion, the versatile phytochemical composition of Filipendulae Ulmariae Herba
was comprehensively characterised for the first time with two complementary generic
UHPLC-PDA-amMS methods. Selective ion fragmentation with a hybrid quadrupole-orbital
trap MS analyser proved to be a valuable tool for identification of unknown compounds
in a complex matrix such as F. ulmaria . A total of 119 compounds (not including isomers) were tentatively identified, of
which 69 compounds have never been reported in F. ulmaria before. Several metabolic precursors of salicylic acid, the in vivo metabolite responsible for part of the pharmacological activity of F. ulmaria , were detected. However, next to salicylates, a rich diversity of phenolic constituents
(including various oligomeric phenols) was tentatively identified. Only few and often
low abundant non-phenolic phytochemicals were detected. Various detected phytochemicals
are reported to be beneficial for human health, however, in view of the phenolic nature
of the main constituents, extensive metabolisation after oral intake before absorption
can be expected. This urges the need for research towards the identification and activity
of the intestinal, colonic, and hepatic metabolites of F. ulmaria .
Materials and Methods
Chemicals
UHPLC-grade methanol, acetonitrile, and ethyl acetate were purchased from Biosolve.
Ultrapure water with a resistivity of 18.2 × MΩ × cm at 25 °C was generated with a Millipore system. Dichloromethane for gas chromatography,
n -hexane for gas chromatography, acetone for gas chromatography, and sodium hydrogen
carbonate were purchased from Merck. Formic acid, acetic acid, ammonium formate, ammonium
acetate, (D-Ala2 )-leucine encephalin, butylated hydroxytoluene (BHT), and sand (quartz) were supplied
by Sigma-Aldrich. Commercially available mixtures to calibrate the mass spectrometer,
i.e., MSCAL5–1EA (caffeine, tetrapeptide “Met-Arg-Phe-Ala”, Ultramark) for the positive
ion mode and MSCAL6–1EA (sodium dodecylsulfate, taurocholic acid sodium salt, Ultramark)
for the negative ion mode, were purchased from Supelco.
The following analytical standards were purchased from Phytolab: apigenin, luteolin,
isorhamnetin, kaempferol, kaempferol-3-O-glucoside (astragalin), quercetin, quercetin-3-O-glucoside
(isoquercitrin), quercetin-3-O-galactoside (hyperin), quercetin-3-O-rutinoside (rutin),
quercetin-3-O-arabinoside (avicularin), quercetin-3-O-rhamnoside (quercitrin), galangin,
phloretin, naringenin, (+)-catechin, (−)-epicatechin, (+)-dihydrokaempferol [(+)-aromadendrin],
cyanidin-3-O-glucoside chloride (kuromanin chloride), cyanidin-3-O -rutinoside chloride (keracyanin chloride), procyanidin B2, ellagic acid, and eriodictyol.
Analytical standards of salicylic acid, protocatechuic acid, gallic acid, p-coumaric
acid, caffeic acid, chlorogenic acid, β -carotene, stigmasterol, β -sitosterol, miquelianin (quercetin 3-O-glucuronide), tannic acid, γ -tocopherol, α -tocopherol, and quinic acid were obtained from Sigma-Aldrich. Lutein and violaxanthin
were purchased from Carotenature.
Filipendulae Ulmariae Herba (batch number 19 969) was bought from Tilman SA. A certificate
of analysis describing the identification of Filipendulae Ulmariae Herba is in accordance
with the specifications of organoleptic, microscopic, macroscopic, chromatographic,
and steam distillation tests described in the European Pharmacopoeia and was provided
by Tilman SA [41 ].
Preparation of standard solutions
Standard stock solutions for the phenolic analytes were prepared at a concentration
of 1 mg/mL in UHPLC-grade methanol for each analyte separately and stored in the dark
at 4 °C. Dilutions of these solutions were prepared in 60 : 40 (v : v) methanol:40 mM
ammonium formate buffer (aqueous).
Standard stock solutions and working solutions for the non-phenolic analytes were
prepared for each analyte separately at a concentration of approximately 200 µg/mL.
The stock solutions of phytosterols and lipid-soluble vitamins were prepared in methanol
+ 0.1 % BHT. Stock solutions of carotenoids were prepared in dichloromethane + 0.1 %
BHT. Standard stock and working solutions were stored at − 25 °C in the dark under
an inert atmosphere (nitrogen). Dilutions of these solutions were prepared in dichloromethane
+ 0.1 % BHT for analysis.
Sample preparation
The sample material was ground prior to extraction with an MF 10 basic Microfine grinder
drive (IKA-Werke GmbH & Co. KG) using a sieve mesh size of 0.5 mm. Two generic sample
preparation protocols were developed previously with the aim to be complementary in
terms of polarity of extracted compounds [20 ], [21 ]. During this study, these two complementary extraction protocols were combined and
used in parallel for the first time. The combination of the two extraction methods
enables the full range of phytochemical constituents to be extracted. All sample extractions
were performed in triplicate.
Extraction of moderately polar phytochemicals
An extraction protocol previously developed by De Paepe et al. was applied for the
extraction of moderately polar phytochemicals [20 ]. Briefly, 1 g of Filipendulae Ulmaria Herba was extracted with methanol : 40 mM
ammonium formate buffer (aqueous) (20 : 80, v : v) in a first step and 40 mM ammonium
formate in methanol in a second step. Each extraction was performed by ultrasound-assisted
solid-liquid extraction with 10 mL of the appropriate solvent by using a 2200 R-4
Ultrasonic sonicator (40 kHz, 100 W) (Branson Ultrasonic Corporation) for 60 min at
room temperature. After 30 min of extraction, the solutions were vortex mixed (IKA
MS2 Minishaker, IKAWerke GmbH & Co. KG). During sonication, the temperature was kept
below 40 °C. The samples were subsequently centrifuged at 3000 rpm (approximately
1450 g) using an Allegra™ Centrifuge (Beckman Coulter Inc.). Following the two consecutive
extraction cycles, the supernatants were combined, diluted 5 times, and stored at
4 °C until analysis.
Extraction of apolar phytochemicals
A method previously developed by Bijttebier et al. was used for the extraction of
a wide array of apolar phytochemicals [21 ]. Approximately 1 g of Filipendulae Ulmaria Herba was spiked with trans -β -Apo-8′-carotenal (internal standard). The sample was subsequently mixed with approximately
1 g of sodium hydrogen carbonate and sand. Ultrapure water was added until the sample
was hydrated (approximately 3 mL) and was let to rest in the dark under N2 for 30 min to allow swelling of the matrix for better analyte extraction. Afterwards,
the mixture was homogenized with sand and loaded into a 33-mL Accelerated Solvent
Extraction (ASE) cell (Thermo Fisher Scientific). The mixture was extracted 3 times
with 70 : 30 acetone : methanol + 0.1 % BHT (v : v) at 40 °C and 1050 psi. The three
extracts were combined in a separating funnel and 100 mL of 10 % NaCl (aqueous) and
15 mL of hexane was added. The hexane phase was transferred to a recipient after vigorous
shaking and the polar phase was extracted twice more with 15 mL hexane. The combined
hexane fractions were evaporated to dryness, dissolved in 10 mL dichloromethane + 0.1 %
BHT and stored in the dark under nitrogen at − 25 °C until analysis.
Instrumental analysis
Analogous to the complementary extraction methods, two generic LC-PDA-amMS methods
were developed previously on an orbitrap MS (Exactive™; Thermo Fisher Scientific)
with the aim to be complementary in the polarity range of analysed compounds [20 ], [21 ]. These methods were used for the first time in parallel during the current study
to enable the characterisation of the full range of phytochemical constituents. Moreover,
the analytical methods were further improved by using a hybrid quadrupole-orbital
trap MS analyser (Q Exactive™; Thermo Fisher Scientific), thereby enabling selective
ion fragmentation to obtain clean compound spectra.
Because of the limitations in acquisition speed of the orbitrap detector, the sample
extracts had to be analysed 3 times to gather the desired spectral information. A
first analysis was performed by switching polarities (positive and negative) during
ionisation to comprehensively detect compounds in both polarities in a single run.
A second and third analysis was performed to selectively fragment the generated ions
with HCD in the HCD cell before detection with the orbitrap mass analyser. The precursor
ions generated by ionisation were selected for fragmentation based on their abundances
during ddMS2 . These consecutive ddMS2 experiments were performed in positive and negative ionisation modes, respectively.
In cases where ddMS2 did not allow for the full characterisation of the compound substructures because
of insufficient product ions, in-source CID fragmentation was used in combination
with HCD fragmentation to obtain pseudo MS3 spectra.
Analysis of moderately polar phytochemicals
The extracts containing moderately polar compounds were analysed with methodology
adapted from De Paepe et al. [20 ]. For analysis, 5 µL of extract were injected with a CTC PAL™ autosampler (CTC Analytics)
on a Waters Acquity UPLC BEH SHIELD RP18 column (3.0 mm × 150 mm, 1.7 µm; Waters)
and thermostatically (40 °C) eluted with an Accela™ quaternary solvent manager and
a “Hot Pocket” column oven (Thermo Fisher Scientific). The mobile phase solvents consisted
of water + 0.1 % formic acid (A) and acetonitrile + 0.1 % formic acid (B), and the
gradient was set as follows (min/A%): 0.0/100, 9.91/74, 18.51/35, 18.76/0, 20.76/0,
20.88/100, 23.00/100. For detection, an amMS (Q Exactive™; Thermo Fisher Scientific)
was used with HESI. During the first analysis, full scan data were acquired using
polarity switching with a m /z range of 120–1800 and resolving power set at 70 000 at FWHM. The spray voltage was
set at ± 2.5 kV, sheath gas and auxiliary gas at 47 and 15 (adimensional), respectively,
and capillary temperature at 350 °C. Data were also recorded using ddMS2 in the positive and negative ionisation modes (one analysis per mode) to obtain additional
structural information (resolving power set at 17 500 FWHM, stepped collision energy
10, 30, 50 V, isolation window: 4 m /z , top 10 of most abundant ions selected for fragmentation). The PDA detector was set
to scan from 190 to 800 nm during all analyses.
Analysis of apolar phytochemicals
The extracts containing apolar compounds were analysed with methodology adapted from
Bijttebier et al. [21 ]. For analysis, 1.25 µL of extract was injected on a Waters Acquity UPLC HSS C18
SB column (2.1 mm × 100 mm, 1.8 µm; Waters) and thermostatically (35 °C) eluted. The
mobile phase solvents consisted of 50 : 22.5 : 22.5 : 5 (v : v : v : v) water + 5 mM
ammonium acetate : methanol : acetonitrile : ethyl acetate (A) and 50 : 50 (v : v)
acetonitrile : ethyl acetate (B), and the gradient was set as follows (min/A%): 0.0/90,
0.1/90, 0.8/70, 20.0/9, 20.1/0, 20.4/0, 20.5/90, 23.0/90. Atmospheric pressure chemical
ionisation (APCI) was used as an MS ionisation technique. During the first analysis,
full scan data were acquired using polarity switching with a m /z range of 90–1400 and resolving power set at 70 000 at FWHM. The corona discharge
current was set at ± 5 µA, the vaporizer and capillary temperatures were set at 450 °C
for both the positive and negative APCI. Lock mass correction with (D-Ala2 )-leucin enkephalin was applied. Data were also recorded using ddMS2 in the positive and negative ionisation modes (one analysis per mode) to obtain additional
structural information (resolving power set at 17 500 FWHM, stepped collision energy
10, 30, 50 V, isolation window: 4 m /z , top 10 of most abundant ions selected for fragmentation). The PDA detector was set
to scan from 190 to 800 nm during all analyses.
